NCT00646126View on ClinicalTrials.gov

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2005

Conditions
Plasmodium FalciparumAsymptomatic ParataemiaSub Patent Parasitaemia
Interventions
DRUG

Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS)

Standard three day regimen

DRUG

placebo tablet similar to active drug in shape and size

Dosage similar to active drug(standard three days regimen)

Trial Locations (1)

11111

Tropical Medicine Research Institute, Khartoum

Sponsors
All Listed Sponsors
collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

International Atomic Energy Agency

OTHER_GOV

lead

Tropical Medicine Research Institute

OTHER